← Open Payments lookup

ELISA HIMEL: Open Payments

NPI 1083047427 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$851 in 52 payments from 11 companies in 2025. Trend: 2023 $1,032 · 2024 $839 · 2025 $851

Food & beverage: $851
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$305
Janssen Pharmaceuticals, Inc6$130
E.R. Squibb & Sons, L.L.C.4$82
Neurocrine BioSciences, Inc.3$75
Otsuka America Pharmaceutical, Inc.3$58
Indivior Inc.3$56
Vanda Pharmaceuticals Inc.1$39
Teva Pharmaceuticals USA, Inc.2$38
Lundbeck LLC1$27
Braeburn Inc.1$23

Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, INGREZZA, SUBLOCADE, REXULTI, FANAPT, ABILIFY ASIMTUFII.

Industry payments across LA — which companies pay providers there.